Annual EBIT
-$432.51 M
+$43.68 M+9.17%
December 31, 2024
Summary
- As of March 16, 2025, GH annual earnings before interest & taxes is -$432.51 million, with the most recent change of +$43.68 million (+9.17%) on December 31, 2024.
- During the last 3 years, GH annual EBIT has fallen by -$50.62 million (-13.25%).
- GH annual EBIT is now -903.15% below its all-time high of -$43.12 million, reached on December 31, 2016.
Performance
GH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$109.64 M
-$2.57 M-2.40%
December 31, 2024
Summary
- As of March 16, 2025, GH quarterly earnings before interest & taxes is -$109.64 million, with the most recent change of -$2.57 million (-2.40%) on December 31, 2024.
- Over the past year, GH quarterly EBIT has increased by +$77.29 million (+41.35%).
- GH quarterly EBIT is now -797.26% below its all-time high of -$12.22 million, reached on June 30, 2019.
Performance
GH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$432.51 M
+$77.29 M+15.16%
December 31, 2024
Summary
- As of March 16, 2025, GH TTM earnings before interest & taxes is -$432.51 million, with the most recent change of +$77.29 million (+15.16%) on December 31, 2024.
- Over the past year, GH TTM EBIT has increased by +$43.68 million (+9.17%).
- GH TTM EBIT is now -1429.00% below its all-time high of -$28.29 million, reached on September 30, 2017.
Performance
GH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GH EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.2% | +41.4% | +9.2% |
3 y3 years | -13.3% | +20.9% | +33.5% |
5 y5 years | -531.0% | +20.9% | +33.5% |
GH EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -13.3% | +33.5% | -53.1% | +52.0% | -13.3% | +34.6% |
5 y | 5-year | -531.0% | +33.5% | -392.2% | +52.0% | -531.0% | +34.6% |
alltime | all time | -903.1% | +33.5% | -797.3% | +52.0% | -1429.0% | +34.6% |
Guardant Health EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$432.51 M(-9.2%) | -$109.64 M(+2.4%) | -$432.51 M(-15.2%) |
Sep 2024 | - | -$107.08 M(+5.1%) | -$509.80 M(+4.5%) |
Jun 2024 | - | -$101.85 M(-10.6%) | -$487.69 M(+6.6%) |
Mar 2024 | - | -$113.94 M(-39.1%) | -$457.47 M(-3.9%) |
Dec 2023 | -$476.19 M(-26.8%) | -$186.94 M(+120.0%) | -$476.19 M(+11.3%) |
Sep 2023 | - | -$84.97 M(+18.6%) | -$427.94 M(-15.1%) |
Jun 2023 | - | -$71.63 M(-46.0%) | -$504.20 M(-23.7%) |
Mar 2023 | - | -$132.65 M(-4.4%) | -$660.91 M(+1.5%) |
Dec 2022 | -$650.87 M(+70.4%) | -$138.69 M(-14.0%) | -$650.87 M(+11.5%) |
Sep 2022 | - | -$161.24 M(-29.4%) | -$583.84 M(+10.3%) |
Jun 2022 | - | -$228.34 M(+86.2%) | -$529.39 M(+33.0%) |
Mar 2022 | - | -$122.61 M(+71.1%) | -$397.90 M(+4.2%) |
Dec 2021 | -$381.89 M | -$71.66 M(-32.9%) | -$381.89 M(-4.1%) |
Sep 2021 | - | -$106.79 M(+10.3%) | -$398.28 M(+9.7%) |
Jun 2021 | - | -$96.85 M(-9.1%) | -$363.09 M(+14.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$106.60 M(+21.1%) | -$315.94 M(+31.0%) |
Dec 2020 | -$241.14 M(+251.8%) | -$88.05 M(+23.0%) | -$241.14 M(+37.5%) |
Sep 2020 | - | -$71.59 M(+44.1%) | -$175.37 M(+50.2%) |
Jun 2020 | - | -$49.70 M(+56.3%) | -$116.79 M(+47.2%) |
Mar 2020 | - | -$31.80 M(+42.8%) | -$79.31 M(+15.7%) |
Dec 2019 | -$68.54 M(-17.4%) | -$22.28 M(+71.2%) | -$68.54 M(-3.7%) |
Sep 2019 | - | -$13.01 M(+6.5%) | -$71.20 M(-12.5%) |
Jun 2019 | - | -$12.22 M(-41.9%) | -$81.39 M(-10.1%) |
Mar 2019 | - | -$21.03 M(-15.7%) | -$90.49 M(+9.1%) |
Dec 2018 | -$82.97 M(+3.1%) | -$24.94 M(+7.5%) | -$82.97 M(+14.0%) |
Sep 2018 | - | -$23.20 M(+8.8%) | -$72.78 M(-6.5%) |
Jun 2018 | - | -$21.32 M(+57.8%) | -$77.87 M(+37.7%) |
Mar 2018 | - | -$13.51 M(-8.4%) | -$56.55 M(+31.4%) |
Dec 2017 | -$80.51 M(+86.7%) | -$14.75 M(-47.9%) | -$43.04 M(+52.1%) |
Sep 2017 | - | -$28.29 M | -$28.29 M |
Dec 2016 | -$43.12 M | - | - |
FAQ
- What is Guardant Health annual earnings before interest & taxes?
- What is the all time high annual EBIT for Guardant Health?
- What is Guardant Health annual EBIT year-on-year change?
- What is Guardant Health quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Guardant Health?
- What is Guardant Health quarterly EBIT year-on-year change?
- What is Guardant Health TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Guardant Health?
- What is Guardant Health TTM EBIT year-on-year change?
What is Guardant Health annual earnings before interest & taxes?
The current annual EBIT of GH is -$476.19 M
What is the all time high annual EBIT for Guardant Health?
Guardant Health all-time high annual earnings before interest & taxes is -$43.12 M
What is Guardant Health annual EBIT year-on-year change?
Over the past year, GH annual earnings before interest & taxes has changed by +$174.69 M (+26.84%)
What is Guardant Health quarterly earnings before interest & taxes?
The current quarterly EBIT of GH is -$107.08 M
What is the all time high quarterly EBIT for Guardant Health?
Guardant Health all-time high quarterly earnings before interest & taxes is -$12.22 M
What is Guardant Health quarterly EBIT year-on-year change?
Over the past year, GH quarterly earnings before interest & taxes has changed by -$22.11 M (-26.02%)
What is Guardant Health TTM earnings before interest & taxes?
The current TTM EBIT of GH is -$509.80 M
What is the all time high TTM EBIT for Guardant Health?
Guardant Health all-time high TTM earnings before interest & taxes is -$28.29 M
What is Guardant Health TTM EBIT year-on-year change?
Over the past year, GH TTM earnings before interest & taxes has changed by -$81.87 M (-19.13%)